Literature DB >> 11346243

Preinfarction angina prevents left ventricular remodeling in patients treated with thrombolysis for myocardial infarction.

A N Nesković1, K Pavlovski, D Bojić, Z Popović, P Otasević, A Vlahović, V Obradović, B Putniković, Z Vasiljević-Pokrajcić, M Bojić, A D Popović.   

Abstract

BACKGROUND: It has been shown that preinfarction angina may have beneficial effects on infarct size and mortality. However, there are no studies that have serially assessed the impact of preinfarction angina on left ventricular (LV) function in a large series of patients. HYPOTHESIS: The study was undertaken to determine whether preinfarction angina (within 7 days before infarction) influences LV remodeling.
METHODS: In all, 119 consecutive patients with acute myocardial infarction were serially evaluated by 2-dimensional echocardiography (on Days 1, 2, 3, and 7; at 3 and 6 weeks; and at 3, 6, and 12 months following infarction). Left ventricular volumes were determined using Simpson's biplane formula and normalized for body surface area. Wall motion score index and sphericity index were calculated for each study. Coronary angiography was performed before discharge.
RESULTS: Preinfarction angina was detected in 39 of 119 patients. Initial echocardiographic and clinical data as well as the incidence of patent infarct-related artery and collaterals were similar for patients with and without preinfarction angina. In the subset of thrombolysed patients, patients with preinfarction angina showed decrease of LV end-diastolic and end-systolic volumes during the follow-up period (p = 0.033 and p = 0.001, respectively), and improvement of wall motion score index (p < 0.001) and ejection fraction occurred (p = 0.001), without changing of LV shape (p > 0.05); in addition, patients with preinfarction angina had smaller LV volumes and higher ejection fraction than did those without angina, from 3 weeks onward. These favorable effects were not detected in patients not treated with thrombolysis.
CONCLUSIONS: These data indicate that preinfarction angina has an inhibiting effect on long-term LV remodeling in patients who underwent thrombolysis for first acute myocardial infarction. It appears that preinfarction angina has no impact on infarct size and early postinfarction LV function.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11346243      PMCID: PMC6655141          DOI: 10.1002/clc.4960240504

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  26 in total

Review 1.  Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms.

Authors:  N B Schiller; P M Shah; M Crawford; A DeMaria; R Devereux; H Feigenbaum; H Gutgesell; N Reichek; D Sahn; I Schnittger
Journal:  J Am Soc Echocardiogr       Date:  1989 Sep-Oct       Impact factor: 5.251

2.  Relationship between antecedent angina pectoris and short-term prognosis after thrombolytic therapy for acute myocardial infarction. Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group.

Authors:  D W Muller; E J Topol; R M Califf; K N Sigmon; L Gorman; B S George; D J Kereiakes; K L Lee; S G Ellis
Journal:  Am Heart J       Date:  1990-02       Impact factor: 4.749

3.  Significance of preinfarction angina for preservation of left ventricular function in acute myocardial infarction.

Authors:  T Hirai; M Fujita; K Yamanishi; A Ohno; K Miwa; S Sasayama
Journal:  Am Heart J       Date:  1992-07       Impact factor: 4.749

Review 4.  Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications.

Authors:  M A Pfeffer; E Braunwald
Journal:  Circulation       Date:  1990-04       Impact factor: 29.690

5.  Antecedent angina pectoris predicts worse outcome after myocardial infarction in patients receiving thrombolytic therapy: experience gleaned from the International Tissue Plasminogen Activator/Streptokinase Mortality Trial.

Authors:  G I Barbash; H D White; M Modan; F Van de Werf
Journal:  J Am Coll Cardiol       Date:  1992-07       Impact factor: 24.094

6.  Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators.

Authors:  M A Pfeffer; E Braunwald; L A Moyé; L Basta; E J Brown; T E Cuddy; B R Davis; E M Geltman; S Goldman; G C Flaker
Journal:  N Engl J Med       Date:  1992-09-03       Impact factor: 91.245

7.  Intravenous nitroglycerin therapy to limit myocardial infarct size, expansion, and complications. Effect of timing, dosage, and infarct location.

Authors:  B I Jugdutt; J W Warnica
Journal:  Circulation       Date:  1988-10       Impact factor: 29.690

8.  Invasive versus conservative strategy after thrombolytic therapy for acute myocardial infarction in patients with antecedent angina. A report from Thrombolysis in Myocardial Infarction Phase II (TIMI II).

Authors:  N A Ruocco; B A Bergelson; A K Jacobs; M M Frederick; D P Faxon; T J Ryan
Journal:  J Am Coll Cardiol       Date:  1992-12       Impact factor: 24.094

9.  Natural history of left ventricular size and function after acute myocardial infarction. Assessment and prediction by echocardiographic endocardial surface mapping.

Authors:  M H Picard; G T Wilkins; P A Ray; A E Weyman
Journal:  Circulation       Date:  1990-08       Impact factor: 29.690

10.  Effects of left ventricular shape and captopril therapy on exercise capacity after anterior wall acute myocardial infarction.

Authors:  G A Lamas; D E Vaughan; A F Parisi; M A Pfeffer
Journal:  Am J Cardiol       Date:  1989-05-15       Impact factor: 2.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.